Revenue
Our revenue arrangements generally consist of a single performance obligation to transfer promised goods or services. We disaggregate revenues from contracts with customers by both operating segments and types of product sold. Reporting by operating segment is pertinent to understanding our revenues, as it aligns to how we review the financial performance of our operations. Types of products sold within each operating segment help us to further evaluate the financial performance of our segments.
The following table disaggregates external customer net sales by major revenue stream:
Fiscal Year Ended March 30, 2025:
(In thousands)Water
Treatment
IndustrialHealth and
Nutrition
Total
Manufactured, blended or repackaged products (1)
$400,849 $319,048 $31,942 $751,839 
Distributed specialty products (2)
— — 113,527 113,527 
Bulk products (3)
39,977 56,035 — 96,012 
Other5,663 7,404 (14)13,053 
Total external customer sales$446,489 $382,487 $145,455 $974,431 
Fiscal Year Ended March 31, 2024:
(In thousands)Water
Treatment
IndustrialHealth and
Nutrition
Total
Manufactured, blended or repackaged products (1)
$327,188 $345,837 $36,375 $709,400 
Distributed specialty products (2)
— — 108,789 108,789 
Bulk products (3)
32,349 55,720 — 88,069 
Other3,752 7,908 1,244 12,904 
Total external customer sales$363,289 $409,465 $146,408 $919,162 
Fiscal Year Ended April 2, 2023:
(In thousands)Water
Treatment
IndustrialHealth and
Nutrition
Total
Manufactured, blended or repackaged products (1)
$271,448 $383,612 $48,575 $703,635 
Distributed specialty products (2)
— — 109,468 109,468 
Bulk products (3)
27,996 77,479 — 105,475 
Other5,481 9,669 1,370 16,520 
Total external customer sales$304,925 $470,760 $159,413 $935,098 
(1)For our Water Treatment and Industrial segments, this line includes our non-bulk specialty products that we either manufacture, blend, repackage, resell in their original form, or direct ship to our customers in smaller quantities, and services we provide for our customers. For our Health and Nutrition segment, this line includes products manufactured, processed or repackaged in our facility and/or with our equipment.
(2)This line includes non-manufactured distributed specialty products in our Health and Nutrition segment, which may be sold out of one of our facilities or direct shipped to our customers.
(3)This line includes bulk products in our Water Treatment and Industrial segments that we do not modify in any way, but receive, store, and ship from our facilities, or direct ship to our customers in large quantities.

Historical Timeline

Fiscal YearFiled
2025May 14, 2025Showing above
2024May 15, 2024
2023May 17, 2023
2022May 18, 2022

About Revenue Disclosures

Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.

Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.